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Background: Readmission after gastrectomy is one of the factors that reﬂect quality of life. Therefore, we
analyzed the several factors related to readmissions after total gastrectomy for early gastric cancer.
Methods: From January 2002 through December 2009, 102 consecutive patients who underwent radical
total gastrectomy for early gastric cancer were enrolled in this study. We evaluated the incidence, cause,
time point, and type of treatment for readmission after discharge; we compared the readmission and
non-readmission groups in regard to clinicopathologic features and postoperative outcomes.
Results: The readmission rate during the ﬁve years after total gastrectomy was 22 of 102 (21.6%). The
most common cause for readmission was esophagojejunostomy stricture (5 cases). The treatment given
for 31 readmissions included 23 conservative therapies, 3 radiologic or endoscopic interventions, and 5
re-operations. No signiﬁcant differences were detected in the clinicopathologic feature, postoperative
outcomes, or 5-year survival rates between the readmission and non-readmission group. No speciﬁc risk
factor was found to be associated with readmission.
Conclusion: Although we could not determine a speciﬁc risk factor associated with readmission after
radical total gastrectomy, prevention of readmission by evaluating the causes and treatments after
radical total gastrectomy can improve the patient’s quality of life.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Worldwide, more than 800,000 patients are diagnosed with
gastric cancer each year. The secondmost common cause of cancer-
related death worldwide is gastric cancer.1 Surgical resection for
gastric cancer is the only therapeutic modality that may be cura-
tive.2 The incidence of early gastric cancer in Korea has been
increasing because of recent improvements in early diagnosis.3
There are several methods of treatment for early gastric cancer,
including endoscopic treatment (e.g., endoscopic submucosal
dissection and endoscopic mucosal resection).4 However, many
cases of early gastric cancer require radical subtotal gastrectomy or
total gastrectomy for the treatment of potential lymph node
metastasis. In addition, minimally invasive subtotal gastrectomy or
total gastrectomy is performed for early gastric cancer.5
Currently, many surgeons as well as patients have focused on
quality of life after gastrectomy.6e8 Readmission after gastrectomyong-A University College of
602-715, Republic of Korea.
ciates Ltd. Published by Elsevier Ltis one of the factors that impact the quality of life. While the
literature contains some studies regarding readmission after
discharge,9e13 reports on readmission after gastrectomy for gastric
cancer are extremely limited.14 Moreover, the literature contains no
reports regarding readmission after radical total gastrectomy for
early gastric cancer.
Therefore, we analyzed the incidence and cause of readmissions
after radical total gastrectomy for early gastric cancer and investi-
gated the risk factors associated with readmission after surgery.2. Patients and methods
From January 2002 through December 2009, 102 consecutive
early gastric cancer patients who underwent radical total gastrec-
tomy performed by three surgeons (Min-Chan Kim, Ki-Han Kim,
and Ghap-Joong Jung) at Dong-A University Medical Center were
enrolled in this study.
A Dong-A gastric data base has been prospectively accumulated
since 2002. Data were prospectively retrieved from surgical and
pathological reports, with follow-up data obtained from the
outpatient clinical data base. We excluded 291 advanced gastric
cancer patients because postoperative chemotherapy can affectd. All rights reserved.
Table 1
Causes and time point of 31 readmissions after radical total gastrectomy for early
gastric cancer.
Reason for readmission <1
month
1e3
months
3 monthse1
year
>1 year Total
EJ stricture 2 2 1 5
General weakness 1 1 1 1 4
Diarrhea 1 1 2 4
Intestinal obstruction 1 2 3
Ileus 3 3
GB stone 2 2
Short bowel syndrome 2 2
CBD stone 1 1
Acute cholecystitis 1 1
Anemia 1 1
Internal herniation 1 1
Small bowel strangulation 1 1
Afferent loop syndrome 1 1
Pneumonia 1 1
Others 1 1
Total 5 7 4 15 31
EJ; esophagojejunostomy.
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identify readmissions associated with only gastric cancer or sur-
gery. During the ﬁrst ﬁve postoperative days, 15 patients died of
other diseases. We reviewed the clinicopathological characteristics,
postoperative outcomes, postoperative morbidities andmortalities,
and survival related to readmission after radical total gastrectomy
for early gastric cancer. We divided the readmission into 4 periods
(<1 month, 1e3 months, 3 months to 1 year, and >1 year). In
addition, the causes for readmission, the time point of readmission,
the number of readmissions, the types of treatment, and the risk
factors associated with readmission were evaluated. In this study,
gastric cancer stage was classiﬁed according to the 7th edition of
the American Joint Committee on Cancer (AJCC) staging criteria.15
All values were expressed as mean  standard deviation (SD).
All patients were managed routinely by a standardized periop-
erative protocol, as follows: (1) no nasogastric intubation or preop-
erativemechanical bowel preparation; (2) minimal spillage of gastric
contents; (3) use of two closed suction drains; (5) sips of water 72 h
postoperatively; (6) a clear liquid diet 4 days postoperatively; (7)
hospital discharge 8 or 9 days postoperatively after a soft diet with
no abnormal clinical symptoms. All patients underwent total gas-
trectomy with Roux en Y esophagojejunostomy and lymphadenec-
tomy for no. 1, 2, 3, 4, 5, 6, 7, 8a, 9, 11p, and 11d lymph nodes.
Follow-up results were obtained from patient hospital records
and telephone survey. Recurrence was determined primarily by
endoscopy, computed tomography, and positron emission tomog-
raphy. All tracked patients were monitored postoperatively by a
routine analysis of blood tests, tumor markers [carcinoembryonic
antigen (CEA) and carbohydrate antigen 19-9(CA19-9)], chest
radiography, endoscopy, and computed tomography. Follow-up
studies were conducted every six months for two years, and
every year thereafter for the next three years.
For statistical analysis, we used SPSS software version 18.0 (SPSS,
Inc, an IBM Company, Chicago, Illinois, USA). The chi-square test or
Fisher’s exact test and Student’s independent t-test, or the Manne
WhitneyU-testwere used to compare the clinicopathologic factors of
patients in the readmission and non-readmission groups of radical
total gastrectomy for early gastric cancer. Null hypotheses of no dif-
ference were rejected if p-values were <0.05. Survival curves were
calculated by the KaplaneMeier method. In addition, we evaluated
the univariate and multivariate risk factors for readmission.Fig. 1. The incidence of readmission according to time point. Thirty-one readmissions
occurred among 22 patients after radical total gastrectomy for early gastric cancer.3. Results
Among 22 patients, 31 readmissions occurred (22 of 102; 21.6%)
after radical total gastrectomy for early gastric cancer.
3.1. Analysis of readmission
Fig. 1 present the time point of readmission for the 22 patients.
The reasons and time points of readmission for the 22 patients are
presented in Table 1. The most common cause for readmission was
esophagojejunostomy stricture (5 cases). One year postoperatively,
ileus was the most common cause of readmission. Among the 22
patients, four were readmittedmore than once (seven times for one
patient; two times for three patients).
3.2. Outcomes and type of treatments for readmission
The mean number of readmissions was 1.4  1.3 and the mean
length of hospital staywhen readmittedwas 6.24.0 days. The type
of treatment for 31 readmissions included 23 conservative thera-
pies, 3 radiologic or endoscopic interventions, and 5 re-operations
(Table 2). In 5 re-operations, there was 1 case of intestinal obstruc-
tion, 1 case of cholelithiasis, 1 case of internal herniation, 1 case of
small bowel strangulation, and 1 case of afferent loop syndrome.
3.3. Clinicopathologic characteristics in both groups (readmission
and non-readmission)
Table 3 presents the clinicopathological features in the read-
mission and non-readmission groups. The comorbidities differed
statistically between the two groups (p ¼ 0.044).Table 2
Outcomes of 31 readmissions among 22 patients after radical total gastrectomy for
early gastric cancer.
Outcomes
Number of re-admissionsa (range) 1.4  1.3 (1e7)
Hospital staya (range) 6.2  4.0 (1e18)
Type of treatment
Conservative therapy (%) 23 (74.2)
Radiologic or endoscopic intervention (%) 3 (9.7)
Re-laparotomy (%) 5 (16.1)
a All values are the mean and standard deviation.
Table 4
Post-Operative outcomes of readmission (RG) and non-readmission groups (NRG).
Post-operative outcomes RG (n ¼ 22) NRG (n ¼ 80) p-Value
Operative method
Open 17 56 0.601
Laparoscopy 5 24
Operative times (minutes)a 221.6  64.0 226.4  58.2 0.741
Initial hospital stay (days)a 10.1  4.5 9.7  4.2 0.525
Post-operative complications
No 17 68 0.518
Yes 5 (19.2%) 12 (15.0%)
Median duration of follow-up
(months, range)
58.6
(14.8e136.4)
74.9
(14.7e130.1)
0.384
Recurrence
No 21 74 1.000
Yes 1 (4.5%) 6 (7.5%)
RG, readmission group; NRG, non-readmission group.
a All values are the mean and standard deviation.
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two groups
Table 4 presents the postoperative outcomes and recurrences
among the readmission and non-readmission groups. There were
no signiﬁcant differences between the groups in regard to operative
method, operative time, initial hospital stay, postoperative com-
plications, median follow-up period, and recurrence. During the
median follow-up period, tumor recurrence was detected in one
case (4.5%) in the readmission group and six cases (7.5%) in the non-
readmission group.
Fig. 2 presents the 5-year overall and disease free survival rates.
The 5-year overall survival rates were 93.8% in the readmission
group and 96.0% in the non-readmission group (p ¼ 0.896). The
disease-free survival rates were 95.2% in the readmission group and
93.1% in the non-readmission groups (p ¼ 0.702).
3.5. Predictive factors associated with readmission
Univariate analysis of factors related to readmission demon-
strated that comorbidities were associated with readmission.
However, there was no single risk factor associated with read-
mission after radical total gastrectomy based on multivariate
analysis (Table 5).
4. Discussion
Despite improvement of the survival of patients with gastric
cancer, it is one of the most common causes of cancer-related death
worldwide.16,17 Recently, laparoscopic surgery for gastric cancer has
become an alternative treatment option. As the popularity of
laparoscopic surgery grows, with the advantages of quicker re-
covery, improved cosmetics, and reduced wound complications,Table 3
Clinicopathological features of readmission (RG) and non-readmission groups
(NRG).
RG (n ¼ 22) NRG (n ¼ 80) p-Value
Age (years)a 62.0  12.0 58.6  11.0 0.217
Gender
Male 14 60 0.294
Female 8 20
BMI (kg/m2)a 22.9  3.4 23.3  2.8 0.598
Co-morbidities
No 10 56 0.044
Yes 12 24
Size of main lesion (mm)a 3.6  2.5 3.7  2.8 0.956
Tumor location
Lower 1 8 0.715
Middle 8 29
Upper 13 43
Resection margin (cm)
Proximal 2.7(0.5e11.0) 3.7 (0.5e12.0) 0.149
Distal 13.0 (3.0e21.0) 12.5 (4.0e23.5) 0.612
T stageb
T0 1 1 0.583
T1a 9 37
T1b 12 42
N stageb
N0 22 69 0.115
N1 0 11
Retrieved lymph nodes (number)a 41.6  18.1 41.6  17.0 0.995
RG, readmission group; NRG, non-readmission group.
p-Values of less than 0.05 were considered to be statistically signiﬁcant are repre-
sented in bold.
a All values are the mean and standard deviation.
b Based on the AJCC 7th TNM classiﬁcation.many surgeons now consider quality of life after gastrectomy. A
number of studies have addressed quality of life after gastrec-
tomy.6e8
Radical total gastrectomy is more difﬁcult due to technical as-
pects and the risk of serious complications. Speciﬁcally, if serious
complications occur after total gastrectomy, it is more often fatal
than it is following gastrectomy for other indications. In most se-
ries, the mortality rate is reported to range from 3% to 10%, and
morbidity rate is reported to range from 20% to 45%.18e20 Lang
et al.21 reported a postoperative morbidity of 339/1114 (30.4%)
among 1114 patients with conventional open total gastrectomy
(COTG). However, other studies have reported postoperative
morbidity rates of 13e14% for COTG.22,23 In addition, in recent
years, as laparoscopic surgery has increased, interest has grown in
regard to postoperative complications following laparoscopic
radical total gastrectomy for gastric cancer. The literature contains a
number of reports regarding the postoperative morbidity and
mortality of laparoscopic total gastrectomy considering.24e26
However, the postoperative morbidity and mortality after laparo-
scopic total gastrectomy is currently still higher than that of lapa-
roscopic distal gastrectomy.26 Moreover, postoperative readmission
due to short- and long-term complications after discharge will
impact quality of life.
We previously published an analysis of readmission after radical
subtotal gastrectomy for early gastric cancer.14 It showed that the
initial hospital stay was signiﬁcantly associated with readmission
after radical subtotal gastrectomy for early gastric cancer. However,
therewas no cases of readmission after radical total gastrectomy for
gastric cancer.
Readmission after surgery can be affected by the extent of sur-
gery and the patients’ preoperative comorbidities. The literature
contains some reports of readmission after surgery. Sanjay et al.9
reported that, with elective laparoscopic cholecystectomy, the
readmission rate within the ﬁrst 6 weeks was 43 of 1523 (2.8%), and
the 5-year readmission rate was 101 of 1523 (6.6%). The most
common causes for readmission were non-speciﬁc abdominal pain
(36%), obstructive jaundice (14%), and peptic ulcer disease (10%).
However, the risk factors for readmission were not been shown.
Scheneider et al.27 reported that, with colorectal surgery for colon
cancer, the 30-day readmission rate was 16,753 of 149,622 (11.2%).
The most common causes for readmission were operative compli-
cations (21.8%), dehydration (21.5%), and postoperative infection
(18.3%). The risk factors associated with readmission included age
75 years or older, Charlson comorbidities 3, rectal vs. non-rectal
procedure, and postoperative complications. Datta et al.28 re-
ported that with ileal pouch-anal anastomoses, the 5-year
Fig. 2. Comparison of 5-year overall (A) and disease-free (B) survival rates of radical total gastrectomy for early gastric cancer between the readmission and non-readmission
groups. There was no statistically signiﬁcant difference between the groups (A; p ¼ 0.896, B; p ¼ 0.702). (RG; readmission group, NRG; non-readmission group).
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small bowel obstruction and pelvic sepsis/anastomotic leak; in this
study, only perioperative steroid use was a risk factor for read-
mission. Cima et al.29 reported that in hand-assisted laparoscopic
colorectal surgery, the 30-day readmission rate was 7.2%. The
common causes for readmission were abscess, ileus/small bowel
obstruction and dehydration. The risk factors for readmission were
not described.
Two reports showed that the risk factor for patients’ read-
mission was the presence of comorbidities.27,30 Both studies were
large series that attempted to determine risk factors for read-
mission. They found that one of risk factors was the presence of
comorbidities. Although our study was a small series (102 patients)
who underwent a radical total gastrectomy, we found a statistically
signiﬁcant difference in comorbidities with univariate analysis that
compared the readmission group and non-readmission group.
However, unfortunately, no statistically signiﬁcant risk factor was
found with multivariate analysis.
If our study had included more patients or was a multicenter
study, we might have been able to determine the most common
risk factors for the readmission after radical total gastrectomy for
early gastric cancer.Table 5
Univariate and Multivariate Logistic Regression Analysis for Predictable Factors
associated with Readmission.
Variables Univariate analysis Multivariate analysis
OR 95% CI p-Value OR 95% CI p-Value
Age (year)
<60 vs.  60 2.41 (0.86, 6.80) 0.096 1.93 (0.66, 5.68) 0.230
Gender
Male/female 1.71 (0.67, 4.69) 0.293
BMI (Kg/m2)
<23.0 vs.  23.0 1.12 (0.43, 2.93) 0.812
Comorbidity
No vs. yes 2.80 (1.07, 7.36) 0.037 2.38 (0.88, 6.47) 0.089
Operation method
Laparoscopy vs. open 1.46 (0.48, 4.40) 0.505
Complication
No vs. yes 1.67 (0.52, 5.38) 0.392
Tumor recurrence
No vs. yes 0.59 (0.08, 5.15) 0.631
OR, odds ratio; CI, conﬁdence interval.5. Conclusions
This study was a retrospective, observational study. Although
we were unable to determine the risk factors associated with
readmission after radical total gastrectomy, prevention of read-
mission via consideration of the causes and treatments after radical
total gastrectomy would improve the patient’s quality of life.Ethical approval
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